Treatment of posttraumatic anger: A study into the feasibility and acceptability of a research protocol investigating an EMDR-based intervention directed at reducing trauma related anger symptoms in forensic outpatients*

Treatment of posttraumatic anger: A study into the feasibility and acceptability of a research protocol investigating an EMDR-based intervention directed at reducing trauma related anger symptoms in forensic outpatients* - DAP feasibility study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON50908

Enrollment

Registered

2021-06-14

Start date

2021-09-01

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma and Anger

Interventions

The DAP is an EMDR based treatment and targets anger symptoms (anger rumination, revenge fantasies, arousal, and perceived harm) towards individuals responsible for harming the patient in the past.

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: -Male, older than 18 years - Referred for violent behaviour - Presence of PTSD symptoms as clinically assessed by the therapist supported by a sum score >= 31 on the PTSD Checklist for DSM 5 (PCL-5) in the diagnostic phase - Patients suffer from anger symptoms (i.e. anger rumination, revenge urges and fantasies) demonstrated by a sum score >= 60 on the DIrected Anger Questionnaire (DIRAQ) in the diagnostic phase

Exclusion criteria

Exclusion criteria: - IQ rating below average- or lower, clinically assessed by therapist in the diagnostic phase. In case of doubt, therapists will use the Screener for intelligence and mild intellectual disabilities (Screener voor Intelligentie en Licht verstandelijke beperking; SCIL). If the results are inconclusive, therapists can administer the Wechsler Adult Intelligence Scale IV (WAIS-IV) (Determining patients IQ ratings with the SCIL and WAIS V is standard practice in treatments throughout mental health care organizations). - A psychotic disorder or autism spectrum disorder, or a high suspicion of either disorder clinically assessed by therapist in the diagnostic phase D5b. In het Nederlands

Design outcomes

Primary

Measure	Time frame
To assess feasibility and acceptability of the research design to investigate the DAP protocol as an intervention to reduce anger related PTSD symptoms.	—

Secondary

Measure	Time frame
To determine whether the DAP can be utilized to reduce PTSD related anger symptoms, measured with The State Anger Inventory (STAXI-2) the Directed Anger Questionnaire (DIRAQ) and the PTSD Checklist for DSM-V (PCL-5), at pre- and post treatment. In addition, a relationship is expected between the scales of the STAXI-2 (angry expression) and three personality dimensions neuroticism, conscientiousness and altruism. To investigate this, the NEO-FFI-3 is administered	—

Measure

Time frame

To determine whether the DAP can be utilized to reduce PTSD related anger symptoms, measured with The State Anger Inventory (STAXI-2) the Directed Anger Questionnaire (DIRAQ) and the PTSD Checklist for DSM-V (PCL-5), at pre- and post treatment. In addition, a relationship is expected between the scales of the STAXI-2 (angry expression) and three personality dimensions neuroticism, conscientiousness and altruism. To investigate this, the NEO-FFI-3 is administered

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)